Mechanisms of ketamine-involved regulation of cytochrome P450 gene expression

被引：26

作者：

Chen, Jui-Tai ^{[2
,3
]}

Chen, Ruei-Ming ^{[1
,2
,4
]}

机构：

[1] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 110, Taiwan

[2] Taipei Med Univ, Wan Fang Hosp, Dept Anesthesiol, Taipei 110, Taiwan

[3] Taipei Med Univ, Grad Inst Clin Med, Taipei 110, Taiwan

[4] Taipei Med Univ, Wan Fang Hosp, Drug Abuse Res Ctr, Taipei 110, Taiwan

来源：

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 2010年 / 6卷 / 03期

关键词：

TRANSCRIPTIONAL REGULATION; ACTIN CYTOSKELETON; APOPTOTIC INSULTS; DRUG-INTERACTIONS; N-DEMETHYLATION; INDUCTION; RAT; RECEPTOR; ENZYMES; KINASE;

D O I：

10.1517/17425250903505108

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Importance of the field: ketamine, a widely used intravenous anesthetic agent, is biotransformed by cytochrome P450s (CYPs). Considerable attention is devoted to the ketamine-involved regulation of CYP gene expression. Assessing how ketamine regulates CYP gene expression is significant in recognizing the pharmacology of this anesthetic agent and its clinical application. Areas covered in this review: In this review, the authors discuss the effects of ketamine on the regulation of CYP gene expression and its possible mechanisms from the aspects of cytoskeletal remodeling, mitochondrial dysfunction, and alterations of intracellular ATP levels and calcium homeostasis. What the reader will gain: This review may provide readers with more clues for recognizing and avoiding possible ketamine-drug interactions. Take home message: Ketamine may inhibit CYP3A4 expression possibly through reducing calcium mobilization and mitochondrial ATP synthesis and consequently disturbing cytoskeleton remodeling.

引用

页码：273 / 281

页数：9

共 77 条

[1] RETRACTED: Hepatic CYP3A Suppression by High Concentrations of Proteasomal Inhibitors: A Consequence of Endoplasmic Reticulum (ER) Stress Induction, Activation of RNA-Dependent Protein Kinase-Like ER-Bound Eukaryotic Initiation Factor 2α (eIF2α)-Kinase (PERK) and General Control Nonderepressible-2 eIF2α Kinase (GCN2), and Global Translational Shutoff (Retracted article. See vol. 100, pg. 82, 2021) [J].

Acharya, Poulomi ;

Engel, Juan C. ;

Correia, Maria Almira .

MOLECULAR PHARMACOLOGY, 2009, 76 (03) :503-515

[2]

Adamíková L, 2004, MOL BIOL CELL, V15, P1969, DOI 10.1091/mbc.E03-09-0675

[3] The cytotoxic lymphocyte protease, Granzyme B, targets the cytoskeleton and perturbs microtubule polymerization dynamics [J].

Adrain, C ;

Duriez, PJ ;

Brumatti, G ;

Delivani, P ;

Martin, SJ .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (12) :8118-8125

[4]

ANDREW WH, 2000, J CELL SCI, V113, P4379

[5] Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: Comparison with grapefruit juice [J].

Bailey, DG ;

Dresser, GK ;

Bend, JR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (06) :529-537

[6] Safety of sedation with ketamine in severe head injury patients:: Comparison with sufentanil [J].

Bourgoin, A ;

Albanèse, J ;

Wereszczynski, N ;

Charbit, M ;

Vialet, R ;

Martin, C .

CRITICAL CARE MEDICINE, 2003, 31 (03) :711-717

[7]

BRIAN P, 1990, JAMA-J AM MED ASSOC, V264, P2788

[8] The shape of things to come: An emerging role for protein kinase CK2 in the regulation of cell morphology and the cytoskeleton [J].

Canton, DA ;

Litchfield, DW .

CELLULAR SIGNALLING, 2006, 18 (03) :267-275

[9] Induction of rat hepatic cytochrome P-450 by ketamine and its toxicological implications [J].

Chan, WH ;

Sun, WZ ;

Ueng, TH .

JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2005, 68 (17-18) :1581-1597

[10] Cytoskeleton Interruption in Human Hepatoma HepG2 Cells Induced by Ketamine Occurs Possibly through Suppression of Calcium Mobilization and Mitochondrial Function [J].

Chang, Huai-Chia ;

Chen, Ta-Liang ;

Chen, Ruei-Ming .

DRUG METABOLISM AND DISPOSITION, 2009, 37 (01) :24-31

← 1 2 3 4 5 6 7 8 →